Every vision correction procedure solves the same physics problem — light focusing in the wrong place — with a different tool. Laser procedures resculpt the cornea; lens procedures add or replace optics inside the eye. Which tool fits you is a function of your prescription, your corneal anatomy, your age, and your tolerance for specific trade-offs, and the honest version of that decision tree is what this pillar lays out: how each of the five major procedures works, who each one actually fits, what the published numbers say about outcomes and risks, what it all costs at home and abroad, and how the decision should sequence. Bookmark-length by design.
The Physics in One Paragraph
A well-focused eye bends incoming light to land precisely on the retina. Myopia (nearsightedness) focuses light short of it; hyperopia (farsightedness) focuses beyond it; astigmatism scatters focus because the cornea curves unevenly; presbyopia — the over-40 arm's-length menu problem — is the aging lens losing its zoom. Correction means changing the eye's focusing power: grinding the prescription into the cornea with a laser (LASIK, PRK, SMILE), adding a corrective lens inside the eye (ICL), or replacing the aging natural lens entirely (RLE — mechanically the same operation as cataract surgery, performed before a cataract forces it).
The Five Procedures, Honestly
LASIK — the default for a reason
A femtosecond laser creates a thin hinged flap in the cornea; an excimer laser reshapes the tissue beneath; the flap repositions without stitches. Vision is functional within a day for most patients, discomfort is brief, and modern wavefront-guided platforms produce the outcomes that made LASIK the world's most performed elective surgery — large outcome studies report 20/20 or better in the strong majority of eyes and satisfaction rates around 95–98%. The trade-offs: the flap is permanent anatomy (rare late dislocations, and a small long-term interface), dry-eye symptoms are common for months (usually resolving, occasionally persisting), and candidacy walls are real — enough corneal thickness to leave a safe residual bed, a stable prescription, and no corneal disease. Typical treatable ranges run to roughly −8 to −10 diopters of myopia, +4 of hyperopia, and up to about 6 of astigmatism, varying by platform and surgeon judgment.
PRK — the same laser, no flap, slower road
PRK applies the identical excimer reshaping directly to the corneal surface after removing its outer skin layer (epithelium), which regrows over days. No flap means no flap risks and more treatable tissue — the reason PRK survives as the choice for thinner corneas, some professions (it has long military acceptance history), and contact-sport athletes. The cost is the recovery: days of discomfort, blurry vision for a week or more, and final clarity arriving over weeks to months rather than overnight. Long-term outcomes track LASIK closely; the difference is the road, not the destination.
SMILE — the keyhole alternative
SMILE (small incision lenticule extraction) uses a femtosecond laser to cut a thin lens-shaped disc of tissue inside the cornea, removed through a small incision — no flap, no surface removal. The appeal: flapless biomechanics, a smaller incision that may disturb fewer corneal nerves (studies suggest somewhat less early dry eye than LASIK), and quick recovery. The limits: it treats myopia and astigmatism but not hyperopia, retreatments are less straightforward than LASIK enhancements, and it requires specific platform families — availability follows the equipment. Our dedicated SMILE guide covers candidacy and the newer-generation platforms in depth, and the LASIK vs SMILE evidence comparison weighs the head-to-head literature.
ICL — addition, not subtraction
The implantable collamer lens is a prescription lens placed inside the eye between iris and natural lens — no corneal tissue removed, which is why it serves prescriptions far beyond laser range (roughly −3 to −20 diopters of myopia with astigmatism-correcting versions) and thin or irregular corneas. Modern EVO-generation lenses eliminated the older requirement for a pre-op iris hole. Quality of vision in high myopes is frequently described as excellent — high prescriptions ground into a cornea induce more optical compromise than the same prescription in a purpose-made lens. Trade-offs: it's intraocular surgery (infection risk very low but never zero), lens sizing matters (improper vault can require exchange), and long-term monitoring for cataract and pressure effects is part of the deal. Full treatment in our ICL guide.
RLE — the over-50 conversation
Refractive lens exchange replaces the natural lens with an artificial intraocular lens (IOL) — cataract surgery performed for refractive reasons before a cataract exists. It's the tool that addresses presbyopia and high hyperopia at ages where corneal procedures make less sense, and it permanently forecloses future cataract surgery (already done). The decision inside the decision is the IOL itself — monofocal, multifocal, extended-depth-of-focus, toric — each with distinct visual trade-offs covered in our lens options guide and the dedicated RLE piece. The risk profile is cataract surgery's, plus one flag worth naming: retinal detachment risk after lens removal runs higher in young, highly myopic eyes — a major reason RLE is an over-45/50 tool, not a high-myopia shortcut for the young (that's ICL's job).
The Decision Tree, Sequenced
The honest order of operations: anatomy first, age second, preference last. A comprehensive exam with corneal tomography either qualifies you for laser surgery or it doesn't — thickness, topography regularity, dry-eye status, and prescription stability are gates, not suggestions, and the published disasters in refractive surgery cluster around gates that got waved. If laser is on the table and you're under ~40 with a moderate prescription, LASIK/PRK/SMILE are the field, differentiated by lifestyle and anatomy details. If your prescription exceeds laser range or your cornea disqualifies you, ICL is usually the conversation. Past the mid-40s, presbyopia enters and the question becomes whether correcting distance alone still serves you — monovision strategies, and eventually RLE, join the menu. A surgeon who walks this sequence with you, including telling you which procedures you're not a candidate for and why, is showing you what good screening looks like; the live-site candidacy explainer and after-40 guide go deeper on both gates.
The screening IS the safety
Serious complications in modern refractive surgery are rare, and the rare cases disproportionately trace to screening failures — corneas with undetected early keratoconus ablated into ectasia, dry eye dismissed pre-op that became disabling post-op, unstable prescriptions chased with enhancements. The technology is mature; the variable is the thoroughness of the exam and the surgeon's willingness to say no. A clinic anywhere in the world whose screening feels like a formality before a sale has told you what its complication management will feel like too. Our complication-numbers piece puts honest figures on all of this: the published rates.
What It Costs — Home and Abroad
US published cash prices for 2026 cluster around $2,000–$3,500 per eye for LASIK (SMILE similar or slightly above; PRK slightly below), $4,000–$5,500 per eye for ICL, and $4,000–$7,000+ per eye for RLE with premium lenses — virtually never insured, since it's elective. Abroad, published package ranges for both eyes run roughly $1,200–$2,500 for laser procedures in the major destinations (Turkey, Mexico, Colombia, Czech Republic and regional European hubs), $3,500–$7,000 for bilateral ICL, and RLE varying widely with IOL choice. The percentage savings are real; whether the trip math nets out depends on the follow-up-care question — laser vision correction involves a post-op schedule that doesn't compress into a one-week vacation, and the honest accounting of that trade lives in our abroad-vs-home follow-up math piece and the live cost guide. Colombia-specific programs are covered by our sister sites ColombiaLASIK.com and MedellínLASIK.co.
Published 2026 cash prices per eye, US (USD)
Illustrative US cash-pay ranges from published 2026 industry sources. Not quotes — technology tier, surgeon, and market drive variation. Abroad packages for both eyes frequently undercut single-eye US pricing; see the follow-up-care math before comparing.Outcomes and Honest Expectations
Across the laser procedures, modern platforms deliver 20/20 or better uncorrected vision in the strong majority of appropriately screened eyes, with 20/40 or better (legal driving vision) near-universal — and enhancement (touch-up) rates in the low single-digit percentages for typical prescriptions, higher at the extremes. What the headline numbers undersell: night-vision phenomena (halos, glare, starbursts) are common early and usually fade but persist for a minority; dry-eye symptoms follow the same pattern; and every procedure corrects the prescription you have, not the aging your eyes will do — a 30-year-old's perfect LASIK result still meets presbyopia at 45, and reading glasses arrive on schedule. ICL adds its own honest notes (halos around the lens optic in some, the monitoring commitment), and RLE's premium lenses trade some night-vision quality for spectacle independence in ways patients weight very differently. The satisfied-patient rates are genuinely high in every category; the dissatisfied minority is disproportionately made of people whose expectations were set by marketing rather than by this paragraph.
Recovery, Procedure by Procedure
Recovery expectations differ enough across the five tools that they belong in the decision itself, not the aftermath. LASIK is the famous fast lane: functional vision the next morning for most, back to screens within a day or two, with the fine print being weeks of drops, no eye-rubbing, and a month or so avoiding pools and contact sports while the flap seals. SMILE tracks LASIK closely, sometimes with a softer first day. PRK is the honest slog — three to five days of real discomfort while the surface regrows, a week-plus before comfortable screen work, and best-corrected sharpness arriving over four to twelve weeks; patients who chose PRK knowing this do fine, and patients who expected LASIK's timeline suffer the same recovery and call it a complication. ICL recovery is fast visually (often day-one clarity) with the caveats being intraocular: pressure checks in the first hours and days, and activity restrictions while the incision seals. RLE follows cataract-surgery rhythms — quick visual recovery, weeks of drops, and a neural-adaptation period with multifocal optics where the brain learns the new lens over weeks to months.
Two universal recovery rules cut across all five. First, the drop schedule is the treatment — antibiotic and anti-inflammatory drops on schedule prevent the preventable, and the single most common self-inflicted recovery problem is treating drops casually. Second, follow-up appointments exist because the complications they catch are treatable when caught — a day-one pressure spike, an early flap issue, a healing surface that needs a bandage lens. This is precisely why the abroad version of these procedures has a scheduling problem that the destination marketing rarely mentions, and why the follow-up-care math deserves reading before any booking. The live recovery timeline guide maps all of this week by week.
Five Myths Worth Retiring
"LASIK wears off." The corneal reshaping is permanent; what changes is the rest of the eye — natural prescription drift in some patients, and presbyopia in everyone. The distinction matters because it sets honest expectations for what a touch-up can and can't address. "Everyone's a candidate now." Screening technology improved precisely to find the people who shouldn't have surgery; meaningful percentages of screened patients are deferred or redirected at rigorous practices, and that rate is a quality signal, not a sales failure. "The cheapest laser is the same laser." Platform generation genuinely matters in this field — wavefront-guided and topography-guided treatments, femtosecond flap creation, and eye-tracking speed are not marketing fluff, and a deep-discount price often means older equipment amortized long ago. "ICL is the risky one." Modern EVO-era ICL has a strong safety record; its risks are different in kind (intraocular) rather than larger in size, and for high myopes it's frequently the optically superior answer. "Abroad means substandard." The major destination markets run current-generation platforms with high-volume surgeons — the legitimate concern abroad isn't the surgery day, it's the follow-up calendar, which is a logistics problem with logistics solutions.
Choosing Where — and Who
Whatever the procedure, the verification stack is constant: an ophthalmologist (not an optometrist) performing surgery, subspecialty refractive or cornea credentials where applicable, national board registration you've checked yourself, surgical volume in your procedure specifically, and named technology platforms (laser model and generation are legitimate questions — this is one field where the equipment genuinely matters). Abroad, add the destination diligence our network documents across markets — and treat any clinic quoting you a price before tomography as disqualified, at home or anywhere else. The live safety checklist and surgeon questions pieces operationalize this; getmedicalquotes.com covers the quote anatomy.
Before the Exam: How to Show Up Ready
One practical section most guides skip: the comprehensive exam itself has prerequisites that change its accuracy. Contact lenses warp the cornea's measured shape — soft lenses typically need to come out days to two weeks before tomography, rigid lenses considerably longer, and a clinic that doesn't give you a lens-holiday instruction before measuring is measuring the contact lens, not your cornea. Bring your prescription history (stability over one to two years is a gate, and old records prove it faster than anything else), a list of medications (several affect healing or dry eye), and honesty about your dry-eye reality — the pre-op symptom questionnaire is not the moment for stoicism, because untreated dry eye is both a screening flag and a fixable one. If you're comparing clinics, schedule exams rather than consultations: the thoroughness gap between a tomography-plus-tear-film workup and a quick autorefractor-and-sales-chat is the entire quality signal, available to you before any money moves.
The Bottom Line
Vision correction in 2026 is a mature field with five good tools and no universal answer. Anatomy and age narrow the field before preference gets a vote; screening rigor is the real safety variable; the outcome data is genuinely excellent for well-selected patients; and the abroad math works when — and only when — the follow-up plan survives contact with the calendar. Read the procedure guides linked throughout, get a comprehensive exam with tomography before falling in love with any option, and let the surgeon who says "you're not a candidate for X, here's why" earn your trust for whatever they recommend instead.